Theravance Biopharma, Inc. (TBPH)

20.37 -0.05 (-0.24%) USD  |  NASDAQ  |  Jan 21, 10:05
More

Theravance Biopharma Other Long Term Assets (Quarterly)

Other Long Term Assets (Quarterly) Chart

View Other Long Term Assets (Quarterly) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Long Term Assets (Quarterly) Range, Past 5 Years

View Other Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Long Term Assets (Quarterly) Benchmarks

View Other Long Term Assets (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Skye Bioscience, Inc. Upgrade
Kyntra Bio, Inc. Upgrade
Myomo, Inc. Upgrade